Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Boehringer, Zealand Begin Phase III Program For Obesity Contender Survodutide
Studies Include Cardiovascular Outcomes Trial
Oct 05 2023
•
By
Mandy Jackson
The three-trial Phase III program will begin enrolling patients soon • Source: Shutterstock
More from Clinical Trials
More from R&D